Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways.

Skoien R, Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, Dixon JB, O'Brien PE, Tilg H, Moschen AR, Baumann U, Brown RM, Couper RT, Manton ND, Ee LC, Weltman M, Clouston AD.

Liver Int. 2013 Apr;33(4):624-32. doi: 10.1111/liv.12100. Epub 2013 Jan 29.

PMID:
23356584
2.

Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C.

Gadd VL, Melino M, Roy S, Horsfall L, O'Rourke P, Williams MR, Irvine KM, Sweet MJ, Jonsson JR, Clouston AD, Powell EE.

Liver Int. 2013 Apr;33(4):569-79. doi: 10.1111/liv.12050. Epub 2012 Dec 13.

PMID:
23240894
3.

Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis.

Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR.

Hepatology. 2005 Apr;41(4):809-18.

PMID:
15793848
4.

Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD.

Vespasiani-Gentilucci U, Carotti S, Perrone G, Mazzarelli C, Galati G, Onetti-Muda A, Picardi A, Morini S.

Liver Int. 2015 Feb;35(2):569-81. doi: 10.1111/liv.12531. Epub 2014 Apr 5.

PMID:
24649857
5.

Roles of hepatic progenitor cells activation, ductular reaction proliferation and Notch signaling in morbid obesity.

Liew PL, Wang W, Lee YC, Huang MT, Lee WJ.

Hepatogastroenterology. 2012 Sep;59(118):1921-7. doi: 10.5754/hge10861.

PMID:
22819913
6.

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

Weiner RA.

Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.

PMID:
20460923
7.

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.

Svegliati-Baroni G, Bugianesi E, Bouserhal T, Marini F, Ridolfi F, Tarsetti F, Ancarani F, Petrelli E, Peruzzi E, Lo Cascio M, Rizzetto M, Marchesini G, Benedetti A.

Gut. 2007 Sep;56(9):1296-301. Epub 2007 Mar 28.

8.

Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.

Nobili V, Carpino G, Alisi A, Franchitto A, Alpini G, De Vito R, Onori P, Alvaro D, Gaudio E.

Hepatology. 2012 Dec;56(6):2142-53. doi: 10.1002/hep.25742.

PMID:
22467277
9.

Aberrant centrizonal features in chronic hepatic venous outflow obstruction: centrilobular mimicry of portal-based disease.

Krings G, Can B, Ferrell L.

Am J Surg Pathol. 2014 Feb;38(2):205-14. doi: 10.1097/PAS.0000000000000099.

PMID:
24418854
10.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.

Obes Surg. 2006 Dec;16(12):1584-93.

PMID:
17217634
11.

The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease.

Gadd VL, Skoien R, Powell EE, Fagan KJ, Winterford C, Horsfall L, Irvine K, Clouston AD.

Hepatology. 2014 Apr;59(4):1393-405. doi: 10.1002/hep.26937. Epub 2014 Mar 1.

PMID:
24254368
12.

Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression.

Wood MJ, Gadd VL, Powell LW, Ramm GA, Clouston AD.

Hepatology. 2014 Mar;59(3):848-57. doi: 10.1002/hep.26706. Epub 2014 Jan 27.

PMID:
24037895
13.

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease.

Alkhouri N, De Vito R, Alisi A, Yerian L, Lopez R, Feldstein AE, Nobili V.

J Hepatol. 2012 Dec;57(6):1312-8. doi: 10.1016/j.jhep.2012.07.027. Epub 2012 Aug 4.

PMID:
22871498
14.

Hedgehog pathway and pediatric nonalcoholic fatty liver disease.

Swiderska-Syn M, Suzuki A, Guy CD, Schwimmer JB, Abdelmalek MF, Lavine JE, Diehl AM.

Hepatology. 2013 May;57(5):1814-25. doi: 10.1002/hep.26230. Epub 2013 Apr 1.

15.

Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.

Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):226-32.

PMID:
16469684
16.

Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.

Petta S, Amato MC, Di Marco V, Cammà C, Pizzolanti G, Barcellona MR, Cabibi D, Galluzzo A, Sinagra D, Giordano C, Craxì A.

Aliment Pharmacol Ther. 2012 Jan;35(2):238-47. doi: 10.1111/j.1365-2036.2011.04929.x. Epub 2011 Nov 24.

17.

Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.

Tiniakos DG.

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):930-9. doi: 10.1016/j.gcb.2009.05.009. Epub 2009 Jul 30.

18.

Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease.

Chiba M, Sasaki M, Kitamura S, Ikeda H, Sato Y, Nakanuma Y.

J Clin Pathol. 2011 Jul;64(7):564-70. doi: 10.1136/jcp.2011.090175. Epub 2011 Apr 12.

PMID:
21486894
19.

Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.

Carter-Kent C, Brunt EM, Yerian LM, Alkhouri N, Angulo P, Kohli R, Ling SC, Xanthakos SA, Whitington PF, Charatcharoenwitthaya P, Yap J, Lopez R, McCullough AJ, Feldstein AE.

J Pediatr Gastroenterol Nutr. 2011 Feb;52(2):190-7. doi: 10.1097/MPG.0b013e3181fb47d3.

PMID:
21240012
20.

Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi ZM.

Hum Pathol. 2004 Feb;35(2):196-9.

PMID:
14991537

Supplemental Content

Support Center